REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 103 filers reported holding REVANCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $24,000 | +380.0% | 1,880 | +840.0% | 0.00% | – |
Q3 2018 | $5,000 | -98.7% | 200 | -98.5% | 0.00% | -100.0% |
Q1 2018 | $399,000 | -34.3% | 12,970 | -23.6% | 0.03% | -40.8% |
Q4 2017 | $607,000 | +115.2% | 16,982 | +66.0% | 0.05% | +96.0% |
Q3 2017 | $282,000 | -33.8% | 10,233 | -36.5% | 0.02% | -37.5% |
Q2 2017 | $426,000 | +475.7% | 16,125 | +350.9% | 0.04% | +471.4% |
Q1 2017 | $74,000 | +68.2% | 3,576 | +175.1% | 0.01% | 0.0% |
Q4 2015 | $44,000 | – | 1,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |